KRAS inhibitors market

Jul 29, 2026

The KRAS G12C mutation obstructs the binding of GAP to KRAS, preventing GTP hydrolysis and keeping G12C-mutant KRAS continuously active. This sustained activation triggers the MAPK and PI3K signaling pathways, fueling the formation of tumors. Drugs like sotorasib and adagrasib directly target KRAS G12C by forming a...

May 01, 2026

The American Association for Cancer Research (AACR) is the world's oldest and largest professional association related to cancer research. The AACR Annual Meeting 2026 is one of the most prominent global oncology conferences, showcasing cutting-edge advances across cancer biology, translational research, and early ...